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2 Roswell Park Cancer Institute and 3 School of Dental Medicine, SUNY at Buffalo, Buffalo, New York, U.S.A. 
Objectives: thrombolytzc therapy is frequently used to manage vascular graft thrombos~s. However, long-term patency 
after thrombolyszs remazns poor. The purpose of thzs study was to character~se the morphological nd functional response 
of endothehal cells (EC) exposed to a thrombus and subsequently l tzc therapy. 
Methods: human EC were exposed to human whole blood thrombus for 2, 6, 12, and 24 h The thrombus was lysed with 
urokinase. Cell morphology was studied wzth electron m~croscopy. Northern blot analyses were performed with human 
c-DNA probes for endothehn-1, thrombomoduhn, tissue factor, tzssue plasmmogen activator, plasmmogen activator 
mhzbztor, and trlose phosphate isomerase. 
Results: EC retraction occurred for each period of mcubatzon. Thrombomoduhn expression was zncreased 2.2-fold at 6 h 
and 2 4-fold at 24 h. t-PA expresston was depressed proportzonally to the durahon of thrombus exposure. PAl and TF 
expresswn transzently ~ncreased 1.5-fold at 2 h of exposure and returned to basehne at 6 h. Endothehn expression remained 
unchanged 
Conclusions, except for a transzent zncrease m TF expression and reversal of the tPA/PAI ratio, EC exposed to thrombus 
do not appear to become actzvely procoagulant. The ~ncrease zn TM expression may reflect enhanced thromboresistance. 
However, EC retractzon may be responszble for an ~ncrease thrombogemc~ty of saphenous vezn graft after thromboszs and 
Urok~nase therapy. 
Introduction fibrinolytic system. In addition, the endothelium reg- 
ulates vascular tone, permeability, and provides a 
Thrombolytic therapy is frequently used for the man- barrier between blood coagulation factors and the 
agement of graft thrombosis; however, long-term subendothelial matrix. However, endothelium is cap- 
results after such therapy remain poor. Berkowitz et able of responding to abnormal stimuli by altering its 
al. showed that thrombosed saphenous vein grafts that properties and functions. Multiple studies have shown 
have been implanted for more than 10 months have a that endothelial cells lose some of their anti-thrombo- 
45% 5-year patency rate following thrombolytic ther- genic properties when activated by thrombin, cyto- 
apy. ~ The patency rate decreased to21% when the vein kines, endotoxins, and fibrin clots. 3-60kajima et al. 
graft has been implanted for less than 10 months. Hye suggested that plasmm generated during thrombolytic 
et al. presented similar results and demonstrated that therapy directly damaged the endothelial barrier func- 
synthetic grafts had a greater tolerance to thrombosis tion, endothelial cell integrity, and non-thrombogenic 
compared to saphenous vein grafts. 2 properties. 7 
It has been postulated that the enhanced pro- In the present study the endothelial cells response 
coagulant activity of the endothelium ay be partially to a whole blood thrombus and thrombolysis was 
responsible for the increase rate of graft failure after investigated by measuring the expression of factors 
thrombolytic therapy. The normal endothelium pro- involved in the coagulation and fibrinolysis. In ad- 
vides a metabolically active non-thrombogenic surface dition, changes of endothelial cells morphology were 
by producing inhibitors of coagulation and platelet studied by scanning electron microscopy. 
activation, and participating in the regulation of the 
Materials and Methods 
Materzals 
* Presented atXI Annual Meeting of the European Society for 
Vascular Surgery, Lisbon, Portugal, 17-20 September, 1997. M199 medium, fetal bovine serum (FBS), calf serum, 
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Surgery, Mdlard Fillmore Hospital, 3 Gates Circle, Buffalo, vitamins, minimal essential amino acids, penicillin- 
NY 14209 streptomycin mixture, gentamicin, trypsin, calcium 
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and magnesium free Dulbecco's phosphate buffer sa- Cell characterisation 
line (PBS), and minimal essential media were obtained 
from Life Technologies (Grand Island, NY, U.S.A.). The cell cultures were characterised by immuno- 
Insulin, sodium pyruvate, and ethylenedianne t tra- peroxidase staining using monoclonal antibodies 
acetic acid (EDTA) were from Sigma (St. Louis, MI, against Ulex Europaeous, Factor VIII, EN4, and a- 
U.S.A.). Collagenase/dispase mixture was from Boehr- actin. The EC were seeded in 96-well plates and grown 
inger-Mannheim (Indianapolis, IN, U.S.A.). Heparin to confluency. The cells were then washed and the 
was purchased from Elkins-Sinn (Cherry Hill, NJ, primary antibodies were added and incubated for 
U.S.A.). Monoclonal antibodies against Ulex Euro- 30 rain. In the next step the link antibody was applied 
paeous and Factor VIII were from Sigma, antibodies followed by washing and incubation with labelled 
against EN4 were from Caltag (Burlingame, CA, antibody. A substrate solution of 3-amino, 9-ethyl- 
U.S.A.), and against ~-actin from Biogenex (San Ra- carbazole was then added. Finally, the cells were coun- 
mon, CA, U.S.A.). Tissue culture dishes were from terstained with Mayer's haematoxylin-eosin olution. 
Becton-Dickinson (Lincoln Park, NY, U.S.A.). Human 
c-DNA probes for triose phosphate isomerase (TPI), 
thrombomodulin (TM), endothelin (ET-1), tissue factor 
(TF), tissue plasminogen activator (t-PA), and plas- Thrombus exposure and thrombolysls 
minogen activator inhibitor (PAI) were previously de- 
scribed, s'9 Plasmid kit and the Qiaquick Gel Extraction EC were plated on 100 x 20 mm tissue culture dishes 
kit were from Qlagen (Chatsworth, CA, U.S.A.). The pre-coated with 1% gelatin and grown to confluency. 
nylon membranes and the Turboblotter gel transfer The cells were then overlaid with freshly harvested 
system were from Schleicher & Schuel (Keen, NH, human whole blood with no anhcoagulant additives. 
U.S.A.). Agarose was purchased from FMC (Rockland, The same donor's blood was used in all experiments 
ME, U.S.A.). The 1 kilobase (Kb) DNA ladder was described. Thrombus formation was observed after 
from Gibco BRL (Gathersburg, MD, U.S.A.). The phos- 15-20 ram. The tissue culture dishes were then in- 
phorimager was from Molecular Dynamics (Sunydale, cubated at 37 °C and 5% CO2 for 2, 6, 12, and 24 h. 
CA, U.S.A.). The Urokinase was a gift from Abbott Thrombus lysis was initiated by adding 10 000 units 
(Chicago, IL, U.S.A.). of Urokinase and 2 ml of human plasma to each tissue 
culture dishes for 20 min. The thrombus was then 
aspirated and the cells washed with PBS until clear of 
Cell cultures all residual thrombus as determined by light micro- 
scopy. The total length of time required for throm- 
Human saphenous vein endothelial cells (EC) were bolysis and cell washing did not exceed 30 rain. 
isolated from macroscopically healthy vessels seg- 
ments harvested uring coronary bypass urgery and 
characterised as previously described. 1° Briefly, sa- 
phenous veins were filled with 0.2% collagenase/ RNA preparatwn 
dispase solution and incubated for 20 min at 37 °C in 
5% CO2. Subsequently the media containing serum RNA was isolated by the acid guanidinium thio- 
was added and centrifuged at 4 °C and 3000 rpm for cyanate-phenol-chloroform extraction technique. 11Im- 
5 mm. The supernatant was aspirated and the cell mediately after thrombus removal and washing the 
pellet resuspended in growth media and plated in cells were detached with trypsin and resuspended in
100 x 20 mm tissue culture dishes. The growth media 5 ml of reagent D (4 M guanidinium thiocyanate, 
contained M199, 10% heat inactivated FBS, 1% vlt- 25ram sodium citrate, pH 7, 0.5% sarcosyl, 0.1 M 2- 
amins, 1% non-essential mino acid, 1% sodium py- mercaptoethanol). Sequentially, 0.5 ml of 2 M sodium 
ruvate, 0.5% penicillin-streptomycin mixture, 0.02% acetate, pH 4, 5 ml of phenol (water saturated), and 
gentamicin, and Heparin 50 units. At confluency, the i ml of chloroform were added. The final suspension 
cells were detached by treatment with 0.05% trypsin/ was cooled on ice for 15 rain and then centrifuged at 
0.02% EDTA solution for 5 min at 37 °C and replated 10 000 g for 20 min at 4 °C. After centrifugation, the 
in T-75 flasks. The cells were grown to confluence in aqueous phase was transferred to a fresh tube and 
growth media and split at a ratio of 1:3. The cultures mixed with an equal volume of isopropanol, and then 
were routinely fed every 48h. The experiments de- placed at -20  °C for at least 1 h. Sedimentation at 
scribed in this work were conducted on cells between 10 000 g was again performed, and the resulting RNA 
passage four and seven, pellet dissolved in 0.3 ml of reagent D, transferred 
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into an Eppendorf tube, and precipitated with equal Cell preparation for scanning electron microscopy and 
volume of isopropanol at -20  °C for I h. After cent- viabzlity study 
rifugation in an Eppendorf centrifuge for 10 rain at 
4 °C the RNA pellet was resuspended in 75% ethanol, The endothelial cells were stained for electron micro- 
sedimented, vacuum dried and dissolved in 50 ~tl of scopy by a method previously described. 12Briefly, the 
0.5% SDS. RNA quantification was done by spec- cells were immersed for 5 rain in 1% glutaraldehyde 
trophotometry at260 nm and the samples were stored in 0.1 M cacodylate buffer. They were then washed 
at - 20 °C until analysed. RNA (15 pgm) were elec- with distilled water for 5 mm and dehydrated through 
trophoresed on a 1.5% agarose-formaldehyde gel,and ethanol solutions of 70%, 85%, 95%, and 100%, with 
transferred to a nylon membrane in 10 x SSC solution 5 min m each. The cells were then immersed in hex- 
using the Turboblotter system. The RNA was then amethyl&silazane for 5 min, air-dried at room tem- 
cross-linked to the membrane by UV-radiation. perature and mounted on stainless plated with double 
sticky tabs. The cells were immediately coated with 
gold. The viability was assessed by treating the culture 
Probe preparation with 0.2% trypan blue solution for 5 rain and rinsed 
with PBS for 2 minx 3. The cell viability was de- 
termined by failure of trypan blue incorporation. Escherich~a coli transfected with the probe of interest 
were obtained in lyophilised form. The bacteria were 
grown on Ampicillin agar plates for 18-24 h. A single 
colony was used to inoculate 100 ml of 1 x LB broth Statistical analyszs 
containing 40 ~tgm/ml, the culture was then agitated 
for 18-24 h at 37 °C. Following centrifugation, the bac- The result of all sets of experiments were pooled and 
terial pellets were processed using Qiagen Plasmid expressed as fold change from control (mean + S.E.M.). 
Prep Kits. The plasmid DNA was eluted from the resin Results were analysed by analysis of variance 
column with Tris-EDTA. An aliquot of plasmid DNA 
(10 ~tl) was then incubated with one or more restriction (ANOVA) and by Student's t-test. The significance was 
determined by p<0.05. 
endonuclease(s) and the digest electrophoresed on 
0.8% agarose gel. A commercial DNA ladder was 
added to the gel with the digests. Bands fitting the 
specifications of the desired probes were excised, and 
Results 
processed with Qiagen Gel Extraction Kits. The puri- 
fied probes were eluted with Tris-EDTA and stored at The cells were charactensed as endothelial by the 
-20  °C until needed, typical "cobblestone" growth pattern at confluence. In 
addition, they stained positively with Ulex Euro- 
paeous, Factor VIII, and EN-4 antibodies. No staining 
Hybrldisatzon studies was observed with antibodies against ~-actin, dem- 
onstrating the absence of smooth muscle cells in the 
The membranes were prehybridised in Church buffer cultures. Cell viability was verified for up to 24 h by 
with BSA in a 65°C hybridisation incubator while the trypan blue technique. 
probes were being labeled. Approximately 20 ngH of Confluent EC exposed to a whole blood thrombus 
probe c-DNA were labeled with [32p]~-dATP for 2 h at for 2 h, 6 h, 12 h, and 24 h were studied using S.E.M. 
37 °C. Incorporation yield was between 30% and 80%. After 6 h exposure for thrombus retraction of EC was 
The membranes were then hybndised with the labelled noticed. This effect was maximal at 24 h (Fig. 1). How- 
probe overnight at 65 °C. The membranes were washed ever, the cells remained viable despite morphological 
with blot wash solution (0.045 tool/1 NaC1, 0.0045 mol/1 changes. Interestingly, a similar phenomenon was ob- 
sodium citrate, and 0.5% SDS) at 65 °C for 30 min. served when the cells were treated with urokinase in 
The membranes were first analysed by auto- combination with plasma, but not urokinase alone. 
radiography and then by phosphor imaging for quanti- This suggests that plasmm probably is the factor con- 
tation. The membranes were sequentially probed with tributing to cell retraction following thrombolysis. 
TPI, TM, ET-1, t-PA, PAI, and TF. The membranes In order to examine changes m the pro and anti- 
were chemically striped between probes with tns/ thrombogenic properties of the endothelium, ex- 
SDS solution. The TPI probe was used to normalise pression of thrombomodulin a d tissue factor in endo- 
lane loading, thelial cells exposed to a thrombus for 2 h, 6 h, 12 h, 
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C D 
Fig. 1. Scanning electron mmrograph of endothehal cell cultures incubated with thrombus which was subsequently thrombolysed 
(magnlhcahon x 150) (A) Control cells The cell cultures incubated with thrombus for (B) 6 h, (C) 12 h, and (D) 24 h Cells note retrachon 
and exposure of the subendothehal matrix The severity of the cell retraction increased with the length of thrombus exposure 
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Fig. 2. Thrombomodulm mRNA expression. Human saphenous veto Fig. 4. t-PA and PAI mRNA expression Human saphenous vem EC 
EC were exposed to a thrombus for the time mdlcated Northern were exposed to a thrombus for the time m&cated. Northern blot 
blot analysis (15 pg of total RNA per lane) was performed with analysis (15 pg of total RNA per lane) was performed with t-PA and 
tl~ombomodulin e-DNA probe Blots were analysed by auto- PAI c-DNA probes Blots were analysed by autoradlography and 
ra&ography and quantitated by phosphor imagmg techmques, quantitated by phosphor lmagmg techniques, mRNA levels were 
mRNA levels were normahsed with TPI probe Values represent normahsed with TPI probe Values represent mean of all experiments 
mean of all experiments with s.~ M indmated by vertical bars w~th S.~.M. mdleated by vertical bars (B) t-PA; ([])PAI. 
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Fig. 5. t-PA/PAI mRNA expression ratio. Values represent the mean 
Fig. 3. Tissue factor mRNA expression Human saphenous veto EC of all experiments at each tune points with s E,M indicated by 
were exposed to a thrombus for the time indicated Northern blot vertical bars 
analysis (15 ixg of total RNA per lane) was performed with tissue 
factor c-DNA probe. Blots were analysed by autoradiography and 
quantltated by phosphor imaging techmques mRNA levels were reached statist ical s ignif icance a l ready  at 6 h. In con- 
normahsed with TPI probe. Values represent mean of all expenments trast, PAI expression i creased to 1.5-fold from control 
with S.E.M, mdlcated by vertical bars at 2 h and re turned  to base l ine at 6 h (Fig. 4). Thus, 
the t -PA /PA I  rat io was  decreased after 2, 12 and 24 
and  24 h were  studied.  We observed  a t ime dependent  hours  (Fig. 5). Final ly, endothe l in  express ion was  not  
increase in th rombomodul in  express ion w i th  stat- s igni f icant ly affected by  thrombus  exposure  (Fig. 6). 
ist ical ly s ignif icant 2.2-fold increase at 6 h and  2.4-fold 
increase at 24 h (Fig. 2). TF express ion was  increased 
at 2 h to 1.5-fold f rom control  and  re turned  to base l ine D iscuss ion  
after 6 h. However ,  the changes in TF express ion d id  
not  reach statist ical  s ignif icance (Fig. 3). In this s tudy  we have demonst ra ted  that th rombus  
In our  mode l  t-PA express ion was  depressed  pro-  exposure  and thrombolys ls  does not  enhance endo-  
por t iona l ly  to the durat ion  of th rombus  exposure  and  thel ial  p rocoagu lant  act iv i ty and  only s l ight ly  alter 
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2 umbilical vein endothelial cells exposed to plasmin 
lose their barrier function and decrease thrombo- 
modulin expression. 7 They concluded that high local 
plasmin level may be responsible for early re- 
g T thrombosis following thrombolytic therapy. In their 
~-  study the effect of plasmin on the endothelial cell 
® 1 T T monolayer permeability was noticed as early as after 
10 min of incubation. 
I The fibrinolytic system of the endothelium is reg- 
/ ulated by t-PA and its inhibitor PAI-1. The available 
data regarding the role of endothelium in modulation 
of fibrinolysis is unclear. Gelehrter et al. demonstrated 
0 - -  that thrombin increase the activity of both t-PA and 
0 2 6 12 24 
PAI, although the PAI activity increased several folds Length of thrombus exposure (h) 
over t-PA which resulted m a net decrease in fibrino- 
Fig. 6. Endothelm RNA expressmn Human saphenous vein EC lytic activity. 4It has been demonstrated that fibrinolysis 
were exposed to a thrombus for the t~me m&cated Northern blot lS depressed in EC exposed to an hypoxic environment 
analysis (15 gg of total RNA per lane) was performed with endothelm 
c-DNA probe Blots were analysed by autora&ography and quant- (PaO2 40 mmHg), mainly due to decrease at t-PA ex- 
itated by phosphor tmagmg techmques mRNA levels were nor- pression and unchanged PaI expression. 17In contrast, 
malised with TPI probe Values represent mean of all experiments Gertler et al. have shown that cultured umbilical vein 
with S EM indicated by vertical bars endothelial cells overlaid by fibrin clot induced a 
slight increase in t-PA and a marked reduction in PAI, 
fibrinolytic function. In contrast, thromboresistance is therefore nhancing EC fibrinolytic activity. 2° In our 
enhanced as illustrated by the increase in thrombo- study the decline in fibrinolytic activity of EC exposed 
modulin expression seen after 6h of thrombus ex- to thrombosis was rather mild, suggesting that EC 
posure, retained their fibrinolytic properties. 
One of the most important mechanisms controlling Endothelin is a very potent vasoconstrictor peptide 
coagulation is the thrombomodulin-protein C path- 
way where thrombomodulin converts thrombin from secreted constituvely by the endothelium stimulated 
a procoagulant toan anticoagulant protease. Thrombin by various cytokines and thrombin stimulated plate- 
has been reported to increase thrombomodulin ex- lets. Recent studies indicate that endothelin may be 
pression in vitro. 13 Thus, the increased expression of capable of modulating platelet function and offer a 
thrombomodulin seen in our model may be a direct protective mechanisms against thrombus for- 
effect of the thrombm generated uring thrombus mation. 21-23 Our results suggest hat endothelin ex- 
formation. The increase of thrombomodulin ex- pression in EC is not affected by thrombus and may 
pressrun suggests it may play an important role in not be involved in the mechanism contributing to the 
mamtaining of non-thrombogenic proprieties of endo- early graft failure following thrombolysis. 
thelium exposed to a thrombus. In the present study we did not address the issue 
Normal endothelial cells express httle or no tissue of EC hypoxia as well as EC recovery following throm- 
factor, unless induced by various agents or conditions bolysis. Several m vitro studies have demonstrated that 
including thrombin, IL-1, TNF-~, or hypoxia. 14-17 Ryan hypoxic endothelial cells retain their metabolic activity 
et al. demonstrated that TF expressed by EC is mainly and become procoagulant due to depressed thrombo- 
secreted abluminally into the subendothelial matrix. 18 modulin expression and a decrease t-PA-PAI ratio. 17'2° 
In addition, TF is known to be expressed on the surface Since we did not measure cellular 02 tension, we can 
of pericytes and fibroblasts and therefore could be not determine the degree of hypoxia caused by the 
present at the site of endothelial injury. 19 In the present thrombus layer which may act as a barrier between 
study, TF expression in EC exposed to thrombus and the oxygenated environment and the endothelial cells. 
thrombolysis was not significantly increased. Thus, However, our data suggest that the endothelial injury 
the procoagulant activity of the vessel wall exposed did not occur at the time of thrombus exposure but 
to thrombolytic agents could be due to retraction rather following thrombolysis. 
of the endothelial monolayer and exposure of the In conclusion, we have demonstrated that endo- 
subendothelial matrix rich in TF. It has been suggested thelial cells remain viable and metabolically active for 
that endothelial cell injury and retraction is caused by up to 24 h following thrombus exposure and do not 
plasmin. Okajima et al. have demonstrated that human appear to become actively prothrombogenic, although 
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the fibrinolytic potential of EC seems to be slightly by acid guanldmlum thlocyanate-phenol-chloroform extraction 
Analytical Bmchemistry 1987, 162 156-159. 
depressed. Thus, other mechanism such as an  increase 12 NATION J. A new method using hexamethyldisllazane for pre- 
interaction between EC and leukocytes following paratlon of soft insect issues for scanning electron irucroscopy 
thrombolysis resulting from an increase in adhesion Stazn Technology 1983, 58 347-351 
molecule xpression may be responsible for the endo- 13 BARTHA K, BRISSON C, ARCFIIPOFF G, DE LA SALLE C, LANZA F, 
CAZENAVE JP, BEKCTZ A Thrombm regulates tissue factor and 
thelial injury and graft failure, thrombomodulm RNA levels and activities m human sa- 
phenous veto endothelial cells by distract mechamsm J Biol 
Chem 1993, 268 421-429 
14 BEVILACQUA MP, POBER JS, MAJEAU GR, COTRAN RS, GIMBRONF 
MA JR. Interleukln i (IL-1) reduces biosynthesis and cell surface 
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